Christopher Steer: Can Rebranding Geriatric Assessment Improve Its Adoption in Oncology?
Christopher Steer/LinkedIn

Christopher Steer: Can Rebranding Geriatric Assessment Improve Its Adoption in Oncology?

Christopher Steer, Associate Professor at UNSW, shared on LinkedIn:

“SIOG26 – gerionc thoughts 3

I share Supriya Mohile’s frustration that the uptake of geriatric assessment and guided intervention in older adults with cancer remains low despite the evidence of its clinical utility.

I think one problem is the word ‘geriatric’ especially as the target population is >65yrs American Society of Clinical Oncology (ASCO) guidelines.

Part of the solution may be that we need to rebrand.

At AWRCC we have labelled the GA /GAM process ‘Enhanced Supportive Care’ (it just happens to be in patients >70).”

You can also read: SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia

Christopher Steer: Can Rebranding Geriatric Assessment Improve Its Adoption in Oncology?